Tag: artificial intelligence ai in predictive toxicology market insight

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Artificial Intelligence (AI) In Predictive Toxicology Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

The market size for artificial intelligence (AI) in predictive toxicology has seen rapid expansion over recent years. It is projected to increase from $0.64 billion in 2025 to $0.83 billion in 2026, achieving a compound annual growth rate (CAGR) of 29.3%. The growth witnessed in the past can be ascribed to a growing demand for safer chemicals, increasing pharmaceutical research and development, rising regulatory pressure for chemical safety, early adoption of computational toxicology, and advancements in bioinformatics tools.

The artificial intelligence (ai) in predictive toxicology market is anticipated to experience substantial growth over the coming years. Its valuation is projected to reach $2.29 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 28.9%. This expansion during the projection period is primarily driven by factors such as the increasing integration of AI-powered predictive models, the proliferation of cloud-based platforms for toxicology, the synthesis of genomic and chemical data, enhanced partnerships between pharmaceutical and biotechnology firms, and a surging requirement for swift chemical safety evaluations. Key developments expected within the forecast timeframe encompass the merging of multi-omics data for predicting toxicity, computational drug toxicity modeling, efficient high-throughput toxicological screening, AI-guided chemical prioritization, and cloud-centric management of toxicology data.

Get A Free Sample Report With In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Artificial Intelligence (AI) In Predictive Toxicology Market Industry Drivers: What’s Behind The Revenue Growth?

The growing requirement for effective and ethical drug discovery methodologies is expected to drive the expansion of the artificial intelligence (AI) in predictive toxicology market moving forward. Drug discovery is an elaborate and evolving procedure encompassing the systematic investigation, synthesis, and evaluation of chemical compounds to identify potential therapeutic agents for disease alleviation and overall well-being. Efficient and ethical drug discovery processes involve utilizing advanced technologies and prioritizing responsible research practices to develop new treatments. This increasing demand for streamlined and ethical drug discovery is fueled by the rise in chronic illnesses, the expanding trend toward personalized medicine, and a higher incidence of age-related diseases. Artificial intelligence (AI) in predictive toxicology enhances drug discovery by efficiently analyzing extensive datasets to forecast potential toxicological outcomes, thereby accelerating drug development while ensuring ethical criteria are met. For instance, in 2023, the UK government’s net spending on research and development (R&D) increased to £17.4 ($22.1 billion) billion, up from £16.1 billion ($20.45 billion) in 2022, marking an 8.2% rise, as reported by the Office for National Statistics, a UK-based government agency. Consequently, the rising demand for efficient and ethical drug discovery processes is propelling the growth of the artificial intelligence (AI) in predictive toxicology market.

Artificial Intelligence (AI) In Predictive Toxicology Market Segment Performance And Emerging Opportunities

The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

#Artificial Intelligence (AI) In Predictive Toxicology Market Growth Trends: What’s Shaping The Future Outlook?

Leading firms operating in the artificial intelligence (AI) predictive toxicology market are employing strategic partnership approaches to bolster their market presence and drive innovation. These collaborations are designed to leverage AI and machine learning techniques for enhanced prediction and assessment of the toxicity of chemical compounds and pharmaceuticals. For instance, in January 2024, SyntheticGestalt, a UK-based AI research and development company offering AI drug discovery solutions, partnered with Enamine, a Ukraine-based provider of chemical building blocks, screening compounds, and integrated drug discovery services, to develop a set of AI models. These models aim to facilitate the generation of synthetically accessible biologically active compounds while optimizing their physicochemical and ADME or Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) properties. These new models will be applied in SyntheticGestalt’s compound discovery endeavors, serving both academic users and pharmaceutical companies through their services. Enamine has made its extensive Enamine REAL database, containing 38 billion molecules, available for access. SyntheticGestalt will integrate this database into its Drug Discovery Service, utilizing proprietary AI models to predict the physicochemical and ADME or Tox properties of compounds. The service will promptly suggest improved alternative compounds for those with issues.

Artificial Intelligence (AI) In Predictive Toxicology Market Key Players: Which Companies Lead Industry Competition?

Major companies operating in the artificial intelligence (ai) in predictive toxicology market are Certara Inc, Schrödinger Inc, Instem plc, Simulations Plus Inc, Lhasa Limited, Chemaxon Ltd, Algorithme Pharma, Benevolent AI, Berg Health, Biovista Inc, Recursion Pharmaceuticals Inc, Exscientia plc, Insilico Medicine Inc, Celsius Therapeutics Inc, ArisGlobal, Merative L.P., BioTeam Inc, Leadscope Inc, MultiCASE Inc, ACD Labs, Optibrium Ltd, Chemotargets SL, Toxys BV

View The Full Artificial Intelligence (AI) In Predictive Toxicology Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Artificial Intelligence (AI) In Predictive Toxicology Market Regional Analysis And Top Geography

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in predictive toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Artificial Intelligence (AI) In Predictive Toxicology Market Forecast Highlighting Growth From $0.82 Billion To $2.29 Billion

The market for artificial intelligence in predictive toxicology has seen rapid expansion in recent years, with its value projected to rise from $0.64 billion in 2025 to $0.83 billion in 2026, reflecting a compound annual growth rate (CAGR) of 29.3%. Historical growth was driven by several factors, including a heightened demand for safer chemicals, intensified research and development efforts in pharmaceuticals, stricter regulatory requirements concerning chemical safety, early moves toward computational toxicology, and progress in bioinformatics tools.

In the market for artificial intelligence within predictive toxicology, substantial growth is anticipated over the coming years, with projections indicating it will reach a value of $2.29 billion by 2030, reflecting a compound annual growth rate of 28.9%. This expansion in the forecast period is driven by factors such as the greater uptake of AI-powered predictive models, the proliferation of cloud-based toxicology platforms, the merging of genomic and chemical data sources, heightened partnerships among pharmaceutical and biotechnology entities, and an escalating need for swift chemical safety evaluations. Key developments shaping this period involve the incorporation of multi-omics datasets to enhance toxicity forecasts, the creation of in silico models for drug toxicity assessments, the use of high-throughput screening techniques for toxicological purposes, the improved prioritization of chemicals through artificial intelligence, and the deployment of cloud-based systems for managing toxicology data.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Artificial Intelligence (AI) In Predictive Toxicology Market Opportunity Drivers: What Is Creating New Revenue Potential?

The growing need for faster and more ethical approaches to drug discovery is anticipated to boost the expansion of the artificial intelligence (AI) in predictive toxicology market moving forward. Drug discovery is a complex and dynamic process involving the methodical investigation, synthesis, and assessment of chemical compounds aimed at identifying promising therapeutic agents to treat diseases and improve human health, while efficient and ethical drug discovery processes integrate advanced technologies and prioritize responsible research practices in the creation of new treatments. This demand is fueled by the rise in chronic illnesses, the increasing shift toward personalized medicine, and a higher occurrence of age-related conditions. Artificial intelligence in predictive toxicology streamlines drug development by rapidly processing extensive datasets to forecast potential toxic effects, thus accelerating the timeline and upholding ethical considerations. For example, data from the Office for National Statistics, a UK government body, revealed that in 2023, the UK’s net research and development spending reached £17.4 billion ($22.1 billion), up from £16.1 billion ($20.45 billion) in 2022, representing an 8.2% increase. Consequently, the rising emphasis on efficient and ethical drug discovery is propelling the growth of the artificial intelligence in predictive toxicology market.

Artificial Intelligence (AI) In Predictive Toxicology Market Segment Analysis Highlighting Growth Areas

The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

Artificial Intelligence (AI) In Predictive Toxicology Market Innovation Trends Driving Future Development

Leading players in the artificial intelligence (AI)-driven predictive toxicology sector are increasingly turning to strategic partnerships as a means to strengthen their market position and drive innovation. By combining AI and machine learning techniques, these collaborations aim to refine the ways in which toxicity is predicted and assessed for chemical compounds and pharmaceuticals. A concrete example comes from January 2024, when SyntheticGestalt, a UK-based AI research company focused on drug discovery, joined forces with Enamine, a Ukrainian supplier of chemical building blocks, screening compounds, and integrated drug discovery services. The partnership’s goal was to develop a suite of AI models that support the generation of synthetically accessible, biologically active molecules while optimizing their physicochemical and ADME/Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) characteristics. These models are slated for use in SyntheticGestalt’s compound discovery initiatives, serving both academic researchers and pharmaceutical firms through their service offerings. In a key move, Enamine granted access to its immense REAL database, which holds 38 billion molecules. SyntheticGestalt plans to incorporate this resource into its Drug Discovery Service, relying on proprietary AI models to forecast compounds’ physicochemical and ADME/Tox profiles. When problematic compounds are identified, the service will rapidly propose enhanced alternatives.

Artificial Intelligence (AI) In Predictive Toxicology Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the artificial intelligence (ai) in predictive toxicology market are Certara Inc, Schrödinger Inc, Instem plc, Simulations Plus Inc, Lhasa Limited, Chemaxon Ltd, Algorithme Pharma, Benevolent AI, Berg Health, Biovista Inc, Recursion Pharmaceuticals Inc, Exscientia plc, Insilico Medicine Inc, Celsius Therapeutics Inc, ArisGlobal, Merative L.P., BioTeam Inc, Leadscope Inc, MultiCASE Inc, ACD Labs, Optibrium Ltd, Chemotargets SL, Toxys BV

Access The Complete Artificial Intelligence (AI) In Predictive Toxicology Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Artificial Intelligence (AI) In Predictive Toxicology Market Regional Distribution: Which Areas Drive Market Expansion?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in predictive toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Artificial Intelligence (AI) In Predictive Toxicology Market Over The 2026–2030 Period?

In recent years, the artificial intelligence (ai) in predictive toxicology market has expanded significantly. Forecasts indicate it will increase from $0.64 billion in 2025 to $0.83 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 29.3%. Historically, this expansion has been driven by factors such as a growing demand for safer chemicals, increased pharmaceutical research and development, mounting regulatory pressure concerning chemical safety, the early embrace of computational toxicology, and advancements in bioinformatics tools.

The artificial intelligence (ai) in predictive toxicology market size is anticipated to experience significant expansion over the coming years. This market is projected to reach $2.29 billion by 2030, driven by a compound annual growth rate (CAGR) of 28.9%. Several factors are contributing to this growth during the forecast period, including the increased embrace of AI-powered predictive models, the proliferation of cloud-based toxicology platforms, the incorporation of genomics and chemical information, enhanced partnerships between pharmaceutical and biotechnology firms, and the surging need for swift chemical safety evaluations. Key trends expected over the forecast period encompass the merging of multi-omics data for predicting toxicity, computer-based (in silico) drug toxicity modeling, expedited toxicological screening processes, AI-led chemical prioritization, and the management of toxicology data through cloud solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

Which Key Factors Are Driving The Artificial Intelligence (AI) In Predictive Toxicology Market Growth?

The growing need for effective and ethical drug discovery processes is expected to drive the expansion of the artificial intelligence (AI) in predictive toxicology market in the future. Drug discovery is an intricate and dynamic endeavor that involves systematically exploring, synthesizing, and evaluating chemical compounds to identify potential therapeutic agents capable of alleviating diseases and improving overall well-being. Efficient and ethical drug discovery processes achieve this by leveraging advanced technologies and prioritizing responsible research practices in the development of new therapeutic agents. This demand for efficient and ethical drug discovery processes is fueled by the rising prevalence of chronic diseases, the increasing adoption of personalized medicine, and a greater incidence of age-related illnesses. Artificial intelligence (AI) in predictive toxicology enhances drug discovery by efficiently analyzing extensive datasets to predict potential toxicological outcomes, thereby accelerating drug development while ensuring ethical standards are met. For instance, in 2023, according to Office for National Statistics, a UK-based, government agency, the UK government’s net spending on research and development (R&D) rose to £17.4 billion ($22.1 billion) in 2023, up from £16.1 billion ($20.45 billion) in 2022, indicating an 8.2% increase. Therefore, the increasing demand for efficient and ethical drug discovery processes is a significant driver for the growth of the artificial intelligence (AI) in predictive toxicology market.

How Is The Artificial Intelligence (AI) In Predictive Toxicology Market Categorized Across Its Segment Groups?

The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

Which Trends Are Guiding The Direction Of The Artificial Intelligence (AI) In Predictive Toxicology Market?

Leading companies within the artificial intelligence (AI) predictive toxicology market are employing strategic collaboration tactics to strengthen their market footprint and drive innovation. These partnerships are designed to utilize AI and machine learning technologies for refining the prediction and evaluation of toxicity in chemical compounds and pharmaceuticals. As an illustration, in January 2024, SyntheticGestalt, an AI research and development firm from the UK specializing in AI drug discovery solutions, formed a partnership with Enamine, a Ukraine-based supplier of chemical building blocks, screening compounds, and integrated drug discovery services. Their joint objective is to create a suite of AI models that will enable the generation of synthetically accessible, biologically active compounds, concurrently optimizing their physicochemical and ADME or Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) characteristics. These models are intended for application in SyntheticGestalt’s compound discovery initiatives, serving both academic clients and pharmaceutical enterprises through their offerings. Enamine has made its extensive Enamine REAL database, which comprises 38 billion molecules, accessible. SyntheticGestalt plans to integrate this database into its Drug Discovery Service, where it will deploy proprietary AI models to forecast the physicochemical and ADME or Tox properties of compounds. The service is poised to promptly recommend enhanced alternative compounds for any identified with issues.

Which Firms Are Influencing Competition In The Artificial Intelligence (AI) In Predictive Toxicology Market?

Major companies operating in the artificial intelligence (ai) in predictive toxicology market are Certara Inc, Schrödinger Inc, Instem plc, Simulations Plus Inc, Lhasa Limited, Chemaxon Ltd, Algorithme Pharma, Benevolent AI, Berg Health, Biovista Inc, Recursion Pharmaceuticals Inc, Exscientia plc, Insilico Medicine Inc, Celsius Therapeutics Inc, ArisGlobal, Merative L.P., BioTeam Inc, Leadscope Inc, MultiCASE Inc, ACD Labs, Optibrium Ltd, Chemotargets SL, Toxys BV

Get The Full Artificial Intelligence (AI) In Predictive Toxicology Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Which Region Is The Top Contributor To The Artificial Intelligence (AI) In Predictive Toxicology Market By Share?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in predictive toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Artificial Intelligence (AI) In Predictive Toxicology Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Predictive Toxicology Market 2026, By The Business Research Company

Artificial Intelligence Ai In Predictive Toxicology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Artificial Intelligence (AI) In Predictive Toxicology Market Over The 2026–2030 Period?

The artificial intelligence (ai) in predictive toxicology market has experienced substantial expansion lately. It is anticipated to grow from $0.64 billion in 2025 to $0.83 billion in 2026, achieving a compound annual growth rate (CAGR) of 29.3%. Historically, this expansion was driven by factors such as the increasing need for safer chemicals, intensified pharmaceutical research and development efforts, escalating regulatory demands for chemical safety, the early incorporation of computational toxicology, and progress in bioinformatics tools.

The artificial intelligence (AI) in predictive toxicology market size is projected to experience substantial growth over the next few years. It is expected to expand to $2.29 billion by 2030, achieving a compound annual growth rate (CAGR) of 28.9%. This anticipated expansion during the forecast period is driven by several factors, including the increasing implementation of AI-driven predictive models, the broadening scope of cloud-based toxicology platforms, the fusion of genomics with chemical data, escalating collaborations between pharmaceutical and biotechnology companies, and the growing requirement for swift chemical safety assessments. Prominent trends emerging in the forecast period involve the integration of multi-omics data for predicting toxicity, in silico drug toxicity modeling, advanced high-throughput toxicological screening, AI-powered chemical prioritization, and cloud-based toxicology data management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

Which Economic Or Industry Drivers Are Impacting The Artificial Intelligence (AI) In Predictive Toxicology Market?

The future expansion of the artificial intelligence (AI) in predictive toxicology market is anticipated to be driven by the rising need for effective and morally sound drug discovery methods. Drug discovery is a complex and evolving endeavor, encompassing the methodical investigation, creation, and assessment of chemical compounds to find potential treatments for illnesses and improve health; efficient and ethical drug discovery processes, in particular, utilize cutting-edge technologies and emphasize responsible research approaches for developing new therapeutic agents. This need for efficient and ethical drug discovery processes stems from an increase in chronic diseases, the expanding trend of personalized medicine, and a higher occurrence of age-related ailments. Artificial intelligence (AI) in predictive toxicology improves drug discovery by effectively analyzing extensive datasets to forecast potential toxicological results, thus speeding up drug development and upholding ethical standards. As an illustration, the Office for National Statistics, a UK government agency, reported that the UK government’s net expenditure on research and development (R&D) climbed to £17.4 ($22.1 billion) billion in 2023 from £16.1 billion ($20.45 billion) in 2022, representing an 8.2% increase. Consequently, the heightened demand for efficient and ethical drug discovery methods is fueling the expansion of the artificial intelligence (AI) in predictive toxicology market.

How Is The Artificial Intelligence (AI) In Predictive Toxicology Market Segmented Across Key Categories?

The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

Which Upcoming Trends Are Expected To Influence The Artificial Intelligence (AI) In Predictive Toxicology Market?

Leading firms within the artificial intelligence (AI) predictive toxicology market are increasingly adopting strategic collaboration approaches to bolster their market presence and drive innovation. These partnerships are designed to leverage AI and machine learning techniques, thereby enhancing the prediction and assessment of toxicity for chemical compounds and pharmaceuticals. For instance, in January 2024, SyntheticGestalt, a UK-based AI research and development company known for its AI drug discovery solutions, entered a collaboration with Enamine, a Ukraine-based provider of chemical building blocks, screening compounds, and integrated drug discovery services. This partnership aims to develop AI models that facilitate the generation of synthetically accessible, biologically active compounds, optimizing their physicochemical and ADME or Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) properties. These models are intended for application in SyntheticGestalt’s compound discovery initiatives, supporting both academic users and pharmaceutical companies through their services. Enamine has provided access to its extensive Enamine REAL database, which contains 38 billion molecules. SyntheticGestalt will integrate this database into its Drug Discovery Service, employing proprietary AI models to predict the physicochemical and ADME or Tox properties of compounds. The service will then promptly suggest improved alternative compounds for those found to have issues.

Who Are The Dominant Players Shaping The Artificial Intelligence (AI) In Predictive Toxicology Market Landscape?

Major companies operating in the artificial intelligence (ai) in predictive toxicology market are Certara Inc, Schrödinger Inc, Instem plc, Simulations Plus Inc, Lhasa Limited, Chemaxon Ltd, Algorithme Pharma, Benevolent AI, Berg Health, Biovista Inc, Recursion Pharmaceuticals Inc, Exscientia plc, Insilico Medicine Inc, Celsius Therapeutics Inc, ArisGlobal, Merative L.P., BioTeam Inc, Leadscope Inc, MultiCASE Inc, ACD Labs, Optibrium Ltd, Chemotargets SL, Toxys BV

Read the full artificial intelligence (ai) in predictive toxicology market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

What Are The Top-Performing Regions Within The Artificial Intelligence (AI) In Predictive Toxicology Market?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in predictive toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence (AI) In Predictive Toxicology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14253&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Predictive Toxicology Market 2026, By The Business Research Company

Artificial Intelligence Ai In Predictive Toxicology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai) in predictive toxicology market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Artificial Intelligence (AI) In Predictive Toxicology Market’s size between 2026 and 2030?

The artificial intelligence (ai) in predictive toxicology market has seen significant expansion in recent years. This market is expected to increase from $0.64 billion in 2025 to $0.83 billion in 2026, achieving a compound annual growth rate (CAGR) of 29.3%. The historical growth of the market can be linked to factors such as an escalating demand for safer chemicals, a rise in pharmaceutical research and development efforts, mounting regulatory pressure regarding chemical safety, the initial embrace of computational toxicology, and innovations in bioinformatics tools.

The artificial intelligence (ai) in predictive toxicology market is projected for substantial expansion over the coming years, reaching $2.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 28.9%. This anticipated growth during the forecast period is fueled by factors such as the increasing embrace of AI-powered predictive models, the broadening scope of cloud-based toxicology platforms, the incorporation of genomics and chemical data, enhanced collaboration between pharmaceutical and biotechnology firms, and a growing need for swift chemical safety assessments. Key developments expected within this timeframe involve the synthesis of multi-omics data for predicting toxicity, the development of in silico models for drug toxicity, advanced high-throughput toxicological screening, AI-led chemical prioritization, and efficient cloud-based toxicology data management solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

Which Drivers Are Shaping Strategic Decisions In The Artificial Intelligence (AI) In Predictive Toxicology Market?

The growing necessity for streamlined and morally sound drug discovery methodologies is expected to stimulate the expansion of the artificial intelligence (AI) in predictive toxicology market. Drug discovery is a complex and evolving endeavor, encompassing the methodical exploration, synthesis, and evaluation of chemical compounds to uncover potential therapeutic agents that alleviate diseases and enhance overall well-being. Efficient and ethical drug discovery processes involve utilizing advanced technologies and prioritizing responsible research practices for developing new therapeutic agents. The impetus for efficient and ethical drug discovery processes stems from the increasing occurrence of chronic diseases, the rising inclination towards personalized medicine, and a greater prevalence of age-related diseases. Artificial intelligence (AI) in predictive toxicology improves drug discovery by proficiently examining vast datasets to forecast potential toxicological results, thus expediting drug development while ensuring ethical guidelines are met. For instance, in 2023, the UK government’s net spending on research and development (R&D) climbed to £17.4 ($22.1 billion) billion, an increase from £16.1 billion ($20.45 billion) in 2022, marking an 8.2% rise, according to the Office for National Statistics. Therefore, the escalating requirement for efficient and ethical drug discovery processes is propelling the growth of the artificial intelligence (AI) in predictive toxicology market.

What Segment Classifications Make Up The Artificial Intelligence (AI) In Predictive Toxicology Market?

The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

What Trends Are Projected To Support The Growth Of The Artificial Intelligence (AI) In Predictive Toxicology Market?

Leading companies in the artificial intelligence (AI) predictive toxicology market are adopting strategic collaboration approaches to enhance their market presence and drive innovation. These partnerships aim to utilize AI and machine learning techniques to improve the prediction and assessment of the toxicity of chemical compounds and pharmaceuticals. For instance, in January 2024, SyntheticGestalt, a UK-based AI research and development company specializing in AI drug discovery solutions, teamed up with Enamine, a Ukraine-based provider of chemical building blocks, screening compounds, and integrated drug discovery services. Their collaboration is focused on developing a set of AI models to facilitate the generation of synthetically accessible biologically active compounds, optimizing their physicochemical and ADME or Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) properties. These models will be applied in SyntheticGestalt’s compound discovery efforts, serving both academic users and pharmaceutical companies through their services. Enamine has made its extensive Enamine REAL database, containing 38 billion molecules, available for access. SyntheticGestalt will integrate this database into its Drug Discovery Service, leveraging proprietary AI models to predict the physicochemical and ADME or Tox properties of compounds. The service is designed to promptly suggest improved alternative compounds for those with identified issues.

Which Key Market Players Are Investing In Expansion And Innovation Within The Artificial Intelligence (AI) In Predictive Toxicology Market?

Major companies operating in the artificial intelligence (ai) in predictive toxicology market are Certara Inc, Schrödinger Inc, Instem plc, Simulations Plus Inc, Lhasa Limited, Chemaxon Ltd, Algorithme Pharma, Benevolent AI, Berg Health, Biovista Inc, Recursion Pharmaceuticals Inc, Exscientia plc, Insilico Medicine Inc, Celsius Therapeutics Inc, ArisGlobal, Merative L.P., BioTeam Inc, Leadscope Inc, MultiCASE Inc, ACD Labs, Optibrium Ltd, Chemotargets SL, Toxys BV

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Which Regions Are Poised For Strategic Growth In The Artificial Intelligence (AI) In Predictive Toxicology Market?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in predictive toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Artificial Intelligence (AI) In Predictive Toxicology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14253&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Predictive Toxicology Market 2026, By The Business Research Company

Artificial Intelligence Ai In Predictive Toxicology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai) in predictive toxicology market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Artificial Intelligence (AI) In Predictive Toxicology Market Today And What Will It Reach By 2029?

The artificial intelligence (ai) in predictive toxicology market size has experienced substantial expansion in recent years. It is projected to grow from $0.5 billion in 2024 to $0.64 billion in 2025, at a compound annual growth rate (CAGR) of 29.5%. The expansion observed in the historic period can be attributed to heightened regulatory pressure for toxicity assessment, increasing concerns about chemical safety, the availability of large datasets for model training, escalating costs and ethical considerations linked to animal testing, and a growing demand for faster and more cost-effective toxicity screening methods.

The artificial intelligence (AI) in predictive toxicology market size is anticipated to undergo substantial expansion over the coming years, with projections indicating it will reach $1.83 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 29.9%. This expansion throughout the forecast period is fueled by several factors, including the increasing emergence of explainable AI in toxicology predictions, a rising demand for tailored toxicity assessments, the growing regulatory acceptance and standardization of AI-powered toxicity predictions, an uptick in predictive toxicology outsourcing services, and the broader application of AI in drug discovery and development processes. Noteworthy trends during this period encompass a move towards 3D cell culture models for toxicity testing, the development of federated learning methods for cooperative toxicity prediction, the utilization of generative models to foresee chemical toxicity pathways, the integration of natural language processing for extracting toxicity data from existing literature, and the proliferation of virtual screening platforms designed to prioritize chemical testing.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp

What Factors Are Boosting The Artificial Intelligence (AI) In Predictive Toxicology Market?

The anticipated expansion of the artificial intelligence (AI) in predictive toxicology market is fueled by the growing necessity for effective and morally responsible drug discovery methods. Drug discovery is an intricate and evolving procedure that encompasses the systematic investigation, synthesis, and evaluation of chemical compounds to identify prospective therapeutic agents for alleviating diseases and improving well-being. Efficient and ethical drug discovery processes, in turn, involve leveraging advanced technologies and prioritizing responsible research practices to formulate new therapeutic substances. This demand for streamlined and ethical drug discovery is primarily driven by the increase in chronic diseases, the rising trend towards personalized medicine, and a higher incidence of age-related conditions. Artificial intelligence (AI) in predictive toxicology enhances these discovery processes by expertly analyzing vast datasets to forecast potential toxicological outcomes, thereby accelerating drug development while ensuring ethical standards are upheld. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry, disclosed that total pharmaceutical R&D expenditure in Europe totaled $49,500 million (€44,500 million) in 2022. This figure marked an approximate 6.45% increase from $46,500 million (€42,533 million) in 2021. Thus, the escalating need for efficient and ethical drug discovery processes is propelling the growth of the artificial intelligence (AI) in predictive toxicology market.

How Is The Artificial Intelligence (AI) In Predictive Toxicology Market Categorized By Application, Type, And Region?

The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –

1) By Component: Solution, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Other Technologies

3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints

4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users

Subsegments:

1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems

2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services

How Are Technological Trends Affecting The Artificial Intelligence (AI) In Predictive Toxicology Market Growth?

Leading companies in the artificial intelligence (AI) predictive toxicology market are embracing strategic partnerships to bolster their market presence and drive innovation. These collaborations aim to harness AI and machine learning techniques for enhanced prediction and assessment of the toxicity of chemical compounds and pharmaceuticals. As an illustration, in January 2024, SyntheticGestalt, a UK-based AI research and development company focused on AI drug discovery solutions, formed a partnership with Enamine, a Ukraine-based provider of chemical building blocks, screening compounds, and integrated drug discovery services. Their joint effort is to develop a suite of AI models that facilitate the generation of synthetically accessible biologically active compounds, optimizing their physicochemical and ADME or Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) properties. These models will be applied in SyntheticGestalt’s compound discovery ventures, serving both academic users and pharmaceutical companies through their service offerings. Enamine has provided access to its extensive Enamine REAL database, which comprises 38 billion molecules. SyntheticGestalt will integrate this database into its Drug Discovery Service, employing proprietary AI models to predict the physicochemical and ADME or Tox properties of compounds. The service will efficiently propose improved alternative compounds for those identified with issues.

Who Are The Global Leaders Steering The Artificial Intelligence (AI) In Predictive Toxicology Market Forward?

Major companies operating in the artificial intelligence (AI) in predictive toxicology market are Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International, Medidata Solutions Inc., Certara Inc., Schrödinger, Merative L.P., Molecular Devices LLC, Envigo (Inotiv Inc.), Instem plc, Simulations Plus, Cyprotex, Recursion Pharmaceuticals, Exscientia PLC, BIOVIA Corporation, Lhasa Limited, Chemaxon Ltd., Insilico Medicine Inc., Algorithme Pharma, CiToxLAB, ArisGlobal, Benevolent AI, Berg Health, Cyclica Therapeutics Inc., Celsius Therapeutics, Biovista Inc., BioTeam Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Artificial Intelligence (AI) In Predictive Toxicology Market?

North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in predictive toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=14253&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Predictive Toxicology Market 2025, By The Business Research Company

Artificial Intelligence Ai In Clinical Trials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-clinical-trials-global-market-report

Artificial Intelligence Ai In Operating Room Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-operating-room-global-market-report

Artificial Intelligence In Healthcare Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model